ENTECAVIR RESULTS IN SUBSTANTIAL VIROLOGIC AND BIOCHEMICAL IMPROVEMENT AND HBEAG SEROCONVERSION THROUGH 96 WEEKS OF TREATMENT IN HBEAG(+) CHRONIC HEPATITIS B PATIENTS (STUDY ETV-022) (ABSTR)

GISH, R.G., CHANG, T.T., & DE MAN, R.A.. (2005). ENTECAVIR RESULTS IN SUBSTANTIAL VIROLOGIC AND BIOCHEMICAL IMPROVEMENT AND HBEAG SEROCONVERSION THROUGH 96 WEEKS OF TREATMENT IN HBEAG(+) CHRONIC HEPATITIS B PATIENTS (STUDY ETV-022) (ABSTR). HEPATOLOGY, 42(-), 0-0. SID. https://sid.ir/paper/663161/en

GISH R.G., CHANG T.T., DE MAN R.A.. ENTECAVIR RESULTS IN SUBSTANTIAL VIROLOGIC AND BIOCHEMICAL IMPROVEMENT AND HBEAG SEROCONVERSION THROUGH 96 WEEKS OF TREATMENT IN HBEAG(+) CHRONIC HEPATITIS B PATIENTS (STUDY ETV-022) (ABSTR). HEPATOLOGY[Internet]. 2005;42(-):0-0. Available from: https://sid.ir/paper/663161/en

R.G. GISH, T.T. CHANG, and R.A. DE MAN, “ENTECAVIR RESULTS IN SUBSTANTIAL VIROLOGIC AND BIOCHEMICAL IMPROVEMENT AND HBEAG SEROCONVERSION THROUGH 96 WEEKS OF TREATMENT IN HBEAG(+) CHRONIC HEPATITIS B PATIENTS (STUDY ETV-022) (ABSTR),” HEPATOLOGY, vol. 42, no. -, pp. 0–0, 2005, [Online]. Available: https://sid.ir/paper/663161/en